Literature DB >> 12069818

Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors.

Yoh Takuwa1.   

Abstract

One of the striking activities of the Edg family sphingosine-1-phosphate (S1P) receptors includes receptor isotype-specific, bimodal regulatory activity on cell migration. While Edg1 and Edg3 act as typical chemotactic receptors, Edg5 uniquely acts as a chemorepellant receptor. Consistent with this, Edg1 and Edg3, and Edg5 regulate the activity of the Rho family GTPase Rac positively and negatively, respectively. Thus, Edg isotype-specific, differential regulatory activities on Rac seem to be important as mechanisms underlying the bimodal regulation of cell migration by S1P. Edg5-mediated Rac inhibition involves stimulation of Rac-GTPase-activating protein (GAP) activity, rather than inhibition of Rac-guanine nucleotide exchange factor (GEF) activity. Many cell types including vascular smooth muscle and endothelial cells express more than a single S1P receptor isotype. In these cells, it appears that an integration of the Edg isotype-selective, positive and negative signals on cellular Rac activity is a critical determinant for eventual direction of regulation on cell motility by S1P. Physiological and pathological roles for the repulsive activity of Edg5 receptor remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069818     DOI: 10.1016/s1388-1981(02)00145-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

Review 1.  Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.

Authors:  Roger A Sabbadini
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

2.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 3.  Receptor tyrosine kinase-G-protein coupled receptor complex signaling in mammalian cells.

Authors:  Nigel J Pyne; Catherine M Waters; Jaclyn S Long; Noreen A Moughal; Gabor Tigyi; Susan Pyne
Journal:  Adv Enzyme Regul       Date:  2007-03-06

Review 4.  Lipid mediators in the regulation of endothelial barriers.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Tissue Barriers       Date:  2017-10-30

5.  Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.

Authors:  Noriko Takuwa; Wa Du; Erika Kaneko; Yasuo Okamoto; Kazuaki Yoshioka; Yoh Takuwa
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

Review 6.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

7.  Effect of S1P5 on proliferation and migration of human esophageal cancer cells.

Authors:  Wei-Min Hu; Li Li; Bao-Qian Jing; Yong-Sheng Zhao; Chao-Li Wang; Li Feng; Yong-En Xie
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

8.  Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury.

Authors:  Allison D Grabski; Takuya Shimizu; Jessie Deou; William M Mahoney; Michael A Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

Review 9.  Sphingosine-1-phosphate receptor signalling in the heart.

Authors:  Christopher K Means; Joan Heller Brown
Journal:  Cardiovasc Res       Date:  2009-03-12       Impact factor: 10.787

Review 10.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.